Loading...
XSHE300108
Market cap142mUSD
Dec 23, Last price  
1.58CNY
1D
-15.51%
1Q
-21.78%
Jan 2017
-82.92%
IPO
-75.65%
Name

Ji Yao Holding Group Co Ltd

Chart & Performance

D1W1MN
XSHE:300108 chart
P/E
—
P/S
3.00
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
0.29%
Rev. gr., 5y
-18.15%
Revenues
346m
-29.21%
51,784,09861,591,88078,583,548112,671,734126,594,124159,898,590164,814,146343,262,551678,400,229746,504,134700,439,094942,251,6291,065,807,539648,546,128684,752,355488,941,568346,106,530
Net income
-349m
10,574,15413,361,10723,509,22024,382,11327,332,74930,101,82227,161,22756,701,861135,641,226186,361,271202,464,046216,659,9140-380,305,06300-349,309,644
CFO
0k
13,497,8056,662,01716,643,43914,459,29526,578,09512,476,70418,129,27985,691,947171,166,307102,120,35748,900,01843,181,115212,689,512033,159,13700
Dividend
Jul 16, 20180.05 CNY/sh
Earnings
May 21, 2025

Profile

Ji Yao Holding Group Co., Ltd. engages in the research and development, production, and wholesale of pharmaceutical products. It offers Chinese and western medicines in the areas of pediatrics, cough, gynecology, cardiovascular, antiviral, urology, anti-inflammatory, gastrointestinal, tonic, and rheumatology diseases. Ji Yao Holding Group Co., Ltd. was founded in 2000 and is headquartered in Meihekou, China.
URL
http://www.jiyaogroup.com/
IPO date
Aug 25, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
346,107
-29.21%
488,942
-28.60%
684,752
5.58%
Cost of revenue
346,534
466,521
636,142
Unusual Expense (Income)
NOPBT
(428)
22,421
48,611
NOPBT Margin
4.59%
7.10%
Operating Taxes
3,521
7,683
7,620
Tax Rate
34.27%
15.68%
NOPAT
(3,949)
14,737
40,991
Net income
(349,310)
 
Dividends
Dividend yield
Proceeds from repurchase of equity
(400)
(1)
BB yield
0.02%
0.00%
Debt
Debt current
727,503
948,780
1,207,051
Long-term debt
676,925
575,511
679,001
Deferred revenue
1,725
2,003
2,567
Other long-term liabilities
140,603
70,052
54,261
Net debt
1,300,056
1,408,079
1,785,029
Cash flow
Cash from operating activities
33,159
CAPEX
(4,015)
Cash from investing activities
(3,644)
123,060
Cash from financing activities
36,662
FCF
347,576
242,198
478,076
Balance
Cash
27,609
29,956
25,654
Long term investments
76,762
86,257
75,369
Excess cash
87,066
91,766
66,786
Stockholders' equity
666,015
1,519,307
743,141
Invested Capital
652,273
1,079,648
1,369,830
ROIC
1.20%
2.54%
ROCE
1.89%
3.35%
EV
Common stock shares outstanding
665,986
656,565
656,565
Price
3.24
67.01%
1.94
-55.20%
4.33
11.60%
Market cap
2,157,795
69.41%
1,273,735
-55.20%
2,842,925
11.60%
EV
3,457,851
2,681,814
4,627,954
EBITDA
57,901
98,155
133,070
EV/EBITDA
59.72
27.32
34.78
Interest
158,387
206,616
166,280
Interest/NOPBT
921.54%
342.06%